Drug manufacturer Boehringer Ingelheim on Tuesday disputed a federal health agency’s finding a day earlier that BI’s denials of 340B discounts on its drugs when hospitals use contract pharmacies are illegal.
“Boehringer Ingelheim Pharmaceuticals, Inc. is committed to ensuring that its
…
A federal district judge in Rochester, N.Y., has given four insulin and diabetes drug manufacturers until Oct. 29 to file a motion to dismiss an upstate New York health center’s lawsuit claiming the manufacturers conspired to stop offering 340B pricing
…
A new federal district judge has been assigned to Pharmaceutical Research and Manufacturers of America’s (PhRMA) lawsuit challenging Arkansas’s 340B nondiscrimination act.
PhRMA’s case, filed on Sept. 29, was initially assigned to U.S. District Judge Lee Rudofsky, a Trump appointee.
…
Montana’s at-large Republican U.S. congressman has introduced a bill to impose a host of new conditions on hospital participation in the 340B drug discount program.
First-term U.S. Rep. Matt Rosendale (R-Mont.) isn’t a member of the House Energy & Commerce
…
Half of the Congressional Black Caucus (CBC) has asked Centers for Medicare & Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure to end the nearly 30% cut in Medicare Part B drug payments to 340B hospitals.
Reps. Robin Kelly (D-Ill.) and Lisa
…
A federal appeals court is considering some South Carolina Walgreens customers’ claims that Walgreens, in its capacity as a 340B contract pharmacy and as a 340B contract pharmacy third-party administrator (TPA), violated their privacy rights under South Carolina law.
The
…
The final 340B covered entity registration period of the year began on Friday, Oct. 1 and ends on Friday, Oct. 15. Eligible hospitals, health centers, clinics, and their child sites and contract pharmacies registered during the period can begin participating
…
A senior federal health official informed drug manufacturer Boehringer Ingelheim (BI) today its restrictions on 340B pricing when hospitals use contract pharmacies are illegal and must end immediately, or BI could face civil monetary penalties.
U.S. Health Resources and Services
…
The Biden administration this morning, as widely expected, announced it is rescinding the Trump administration’s regulatory requirement that community health centers pass along all their 340B savings on insulin and EpiPen-like devices to low-income patients with high-cost or no health
…
Pharmaceutical Research and Manufacturers of America (PhRMA) asked a federal district court yesterday to rule that Arkansas’s 340B nondiscrimination act does not require drug manufacturers “to offer price discounts under the 340B program to contract pharmacies in Arkansas.”
PhRMA also
…
×
*Sign up for news summaries and alerts from 340B Report